- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00287898
Telephone-Based Genetic Counseling or Standard Genetic Counseling in Women at Risk of Carrying the BRCA1 or BRCA2 Mutation
Telephone-Based Genetic Counseling; An Equivalence Trial
RATIONALE: Genetic counseling may work as well over the telephone as it does in-person. It is not yet known whether genetic counseling by telephone is more effective than standard (in-person) genetic counseling in women at risk of carrying the BRCA1 or BRCA2 mutation.
PURPOSE: This randomized phase III trial is studying telephone-based genetic counseling to see how well it works compared to standard (in-person) genetic counseling in women at risk of carrying the BRCA1 or BRCA2 mutation.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES:
Primary
- Compare the impact of telephone genetic counseling (TGC) versus standard genetic counseling (SGC) on utilization of BRCA1/BRCA2 testing in women at risk of carrying the BRCA1/BRCA2 mutation.
- Compare the relative efficacy of TGC versus SGC on satisfaction with the counseling process, informed decision making, psychosocial distress, and quality of life.
Secondary
- Identify participant characteristics that predict differential response to TGC.
- Explore the mechanisms by which TGC or SGC impact distress and quality of life.
OUTLINE: This is a randomized, multicenter study. Participants are stratified according to participating site. Participants are randomized to 1 of 2 groups.
- Group 1 (standard genetic counseling): Participants undergo an in-person genetic counseling session. Participants are then given the option of providing blood for genetic testing at the study site. Participants who choose to undergo genetic testing receive their results in-person from their genetic counselor.
- Group 2 (telephone-based genetic counseling): Participants undergo a telephone-based genetic counseling session. Participants who choose to undergo genetic testing receive a pre-labeled blood kit in the mail. Participants receive their results over the phone from their genetic counselor.
After completion of genetic counseling, all participants are followed periodically for 1 year.
PROJECTED ACCRUAL: A total of 600 participants will be accrued for this study.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
District of Columbia
-
Washington, District of Columbia, États-Unis, 20007
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02115-6084
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
-
-
New York
-
New York, New York, États-Unis, 10029
- Mount Sinai School of Medicine
-
-
Vermont
-
Burlington, Vermont, États-Unis, 05405-0110
- Vermont Cancer Center at University of Vermont
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
DISEASE CHARACTERISTICS:
Must have at least 10% chance of carrying the BRCA1/BRCA2 gene, as defined by ≥ 1 of the following:
- First-degree relative of affected family member with a 50% chance of inheriting a BRCA1/BRCA2 mutation
- Second-degree relative with BRCA1/BRCA2 mutation with 25% risk of inheritance (parent deceased)
- Obligate gene carrier or affected woman
- Must live within 100 miles of the Lombardi Comprehensive Cancer Center
- No more than 4 weeks since breast or ovarian cancer diagnosis
- No metastatic or inflammatory breast cancer or ovarian cancer
- No stage III breast or ovarian cancer while undergoing concurrent chemotherapy
PATIENT CHARACTERISTICS:
- No psychiatric illness or cognitive disorder that would preclude informed consent
PRIOR CONCURRENT THERAPY:
- No prior genetic counseling or testing for BRCA1 and/or BRCA2
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Telephone Genetic Counseling
Participants randomized to this arm will receive all genetic counseling via telephone.
|
Participants will receive all genetic counseling via telephone
|
Comparateur actif: Usual Care
Participants randomized to usual care will receive standard in-person genetic counseling.
|
subjects will receive standard in-person genetic counseling
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Uptake of BRCA1/BRCA2 mutation testing as measured by genetic test results at 3 and 6 months
Délai: 6 months
|
6 months
|
Knowledge assessed by genetic testing knowledge measure at post-counseling and 3 months
Délai: 3 months
|
3 months
|
Decision making as assessed by Decisional Conflict Satisfaction at post-counseling and 3 months
Délai: 3 months
|
3 months
|
Quality of life as assessed by SF-12 health survey at 3 and 6 months
Délai: 6 months
|
6 months
|
Distress as assessed by Impact of Events Scale Brief Symptom Inventory MICRA at 3 and 6 months
Délai: 6 months
|
6 months
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Costs by cost measurement post-counseling
Délai: 6 months
|
6 months
|
Management behaviors as assessed by utilization of management options (e.g., mammography, surgery, and chemoprevention) at 6 and 12 months
Délai: 12 months
|
12 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chaise d'étude: Marc Schwartz, PhD, Lombardi Comprehensive Cancer Center
Publications et liens utiles
Publications générales
- Peshkin BN, Kelly S, Nusbaum RH, Similuk M, DeMarco TA, Hooker GW, Valdimarsdottir HB, Forman AD, Joines JR, Davis C, McCormick SR, McKinnon W, Graves KD, Isaacs C, Garber J, Wood M, Jandorf L, Schwartz MD. Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling. J Genet Couns. 2016 Jun;25(3):472-82. doi: 10.1007/s10897-015-9897-6. Epub 2015 Oct 12.
- Schwartz MD, Valdimarsdottir HB, Peshkin BN, Mandelblatt J, Nusbaum R, Huang AT, Chang Y, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Kinney AY, Luta G, Kelleher S, Leventhal KG, Vegella P, Tong A, King L. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol. 2014 Mar 1;32(7):618-26. doi: 10.1200/JCO.2013.51.3226. Epub 2014 Jan 21.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CDR0000450959
- P30CA051008 (Subvention/contrat des NIH des États-Unis)
- R01CA082346 (Subvention/contrat des NIH des États-Unis)
- R01CA108933 (Subvention/contrat des NIH des États-Unis)
- GUMC-2004-133
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Cancer du sein
-
AstraZenecaRecrutementAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerEspagne, États-Unis, Belgique, Royaume-Uni, France, Hongrie, Canada, Corée, République de, Australie
Essais cliniques sur Telephone Genetic Counseling
-
Geneticure, LLCRecrutement
-
Institut Universitari DexeusComplétéInfertilité | Dépistage génétique préimplantatoireEspagne
-
University of MelbourneBeyondblue (The National Depression Initiative)Complété
-
Matthew Bush, MDComplétéPerte d'audition | Troubles auditifsÉtats-Unis
-
Fox Chase Cancer CenterNational Cancer Institute (NCI); Albert Einstein College of Medicine; Christiana... et autres collaborateursComplétéCancer du seinÉtats-Unis
-
American University of SharfahJordan Hospital; Sheikh Khalifa Medical CityInconnueObésité | Chirurgie bariatriqueJordan, Emirats Arabes Unis
-
Academisch Ziekenhuis MaastrichtRecrutementMaladies cardiovasculaires | Facteur de risque cardiovasculairePays-Bas
-
Virginia Commonwealth UniversityNational Institute on Disability, Independent Living, and Rehabilitation...ComplétéLésion cérébrale traumatiqueÉtats-Unis
-
FHI 360University of North Carolina; Ministry of Health, Madagascar; National Reference...Complété
-
Ascension Genesys HospitalUniversity of Pennsylvania; Robert Wood Johnson FoundationComplété